WIM
IDXX icon

Waverton Investment Management’s Idexx Laboratories IDXX Stock Holding History

Waverton Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-228,600
Closed -$15.3M – 97
2014
Q2 		$15.3M Hold
228,600
– – 1% 34
2014
Q1 		$13.9M Hold
228,600
– – 0.66% 37
2013
Q4 		$12.2M Hold
228,600
– – 0.62% 35
2013
Q3 		$11.4M Buy
+228,600
New +$11M 0.67% 34

Other funds holding IDXX

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Waverton Investment Management's IDXX Position: Q3 2014 in Review

Waverton Investment Management sold out of Idexx Laboratories (IDXX) in Q3 2014, closing a stake of 228,600 shares — an estimated $15.3M sold.

Waverton Investment Management first reported a position in IDXX in Q3 2013 and held it in 4 quarters. The position peaked at $15.3M in Q2 2014. 319 funds tracked by Wall St. Rank hold IDXX as of Q3 2014.

  • Waverton Investment Management reported no remaining Idexx Laboratories position as of Q3 2014 after selling out during the quarter.
  • Waverton Investment Management sold 228,600 Idexx Laboratories shares in Q3 2014, an estimated $15.3M.
  • Waverton Investment Management first reported a position in Idexx Laboratories in Q3 2013 and held it in 4 quarters.
  • Waverton Investment Management's Idexx Laboratories position peaked at $15.3M in Q2 2014.
  • 319 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2014.

Based on Waverton Investment Management's 13F filing for Q3 2014, filed 7 Oct 2014.